SPDR® STOXX Europe 600 SRI UCITS ETF EUR Unhedged (Acc)

Reference Data

ISIN IE00BK5H8015
Valor Number 49894453
Bloomberg Global ID
Fund Name SPDR® STOXX Europe 600 SRI UCITS ETF EUR Unhedged (Acc)
Fund Provider State Street Investment Management Kalanderplatz 5, 8045 Zürich
E-Mail: spdrsswitzerland@statestreet.com
Web: www.statestreet.com/im
spdrsswitzerland@statestreet.com (ETF Business)
Fund Provider State Street Investment Management
Representative in Switzerland State Street Bank GmbH, München, Zweigniederlassung Zürich
Zürich
Phone: +41 44 560 50 00
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Fund is to track the performance of European equities.
Peculiarities

Fund Prices

Current Price * 32.22 EUR 21.07.2025
Previous Price * 32.31 EUR 18.07.2025
52 Week High * 33.61 EUR 03.03.2025
52 Week Low * 28.37 EUR 09.04.2025
NAV * 32.22 EUR 21.07.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 470,691,365
Unit/Share Assets *** 470,691,365
Trading Information SIX

Performance

YTD Performance +5.53% 31.12.2024
21.07.2025
YTD Performance (in CHF) +5.08% 31.12.2024
21.07.2025
1 month +0.90% 23.06.2025
21.07.2025
3 months +5.38% 22.04.2025
21.07.2025
6 months +2.16% 21.01.2025
21.07.2025
1 year +3.25% 22.07.2024
21.07.2025
2 years +22.64% 21.07.2023
21.07.2025
3 years +37.62% 21.07.2022
21.07.2025
5 years +64.03% 21.07.2020
21.07.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

ASML Holding NV 4.93%
SAP SE 4.88%
Nestle SA 4.02%
Novartis AG Registered Shares 3.71%
Roche Holding AG 3.59%
Novo Nordisk AS Class B 3.50%
AstraZeneca PLC 3.39%
Unilever PLC 2.45%
Allianz SE 2.45%
Schneider Electric SE 2.40%
Last data update 30.06.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.12%
Ongoing Charges *** 0.12%
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)